SCHEMBL7200353

SCHEMBL7200353

Cc1ccccc1S(=O)(=O)N(C)CCO

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
KMT2A Q03164 4/20 0.52
HPGD P15428 2/20 0.52
KDM4E B2RXH2 4/20 0.48
LMNA P02545 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HCRTR2 O43614 1/20 0.45
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
GSTO1 P78417 1/20 0.43
RXFP1 Q9HBX9 1/20 0.42
MEN1 O00255 1/20 0.42
HSD17B10 Q99714 1/20 0.40
HSD11B1 P28845 1/20 0.39
HTT P42858 1/20 0.39
PTPN1 P18031 1/20 0.39
GAA P10253 1/20 0.38
TDP1 Q9NUW8 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
NSD2 O96028 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10693742 0.86 HCRTR2 (0.47) ALDH1A1KMT2AHPGDKDM4ELMNA
SCHEMBL15829877 0.84 HTR2A (0.44) ALDH1A1KMT2AHPGDKDM4ELMNA
SCHEMBL9683547 0.84 SMN1; SMN2 (0.46) ALDH1A1KMT2AHPGDKDM4ESMN1; SMN2
SCHEMBL17303556 0.83 HTR2A (0.43) ALDH1A1KMT2AHPGDKDM4ELMNA
SCHEMBL4031734 0.81 GSTO1 (0.54) ALDH1A1KMT2AHPGDKDM4EHCRTR2
SCHEMBL4566032 0.80 HCRTR2 (0.48) ALDH1A1KMT2AHPGDLMNAHCRTR2
SCHEMBL17303554 0.80 PRMT6 (0.44) ALDH1A1KMT2AHPGDKDM4ELMNA
SCHEMBL17303835 0.80 HTR2A (0.41) ALDH1A1KMT2AHPGDKDM4ELMNA
SCHEMBL12169372 0.79 TSHR (0.47) ALDH1A1KMT2AHPGDKDM4ESMN1; SMN2
SCHEMBL4891235 0.79 LMNA (0.41) ALDH1A1KMT2AHPGDLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596719-B1 Manufacturing those compounds, pharmaceutical compositions containing one or more of those compounds as endothelin antagonists, and a method of treating a subject having a disorder involving endothelin with the compounds of the ACTELIO PHARMACEUTICALS LTD. (CH) 2003-07-22 US disclosed